Jeremy Whalen, PharmD BCOP is the Specialty Clinical Program Director of Oncology for Prime Therapeutics. In this role, he oversees oncology strategy and program development for pharmacy benefits and integration of medical drug benefits, affecting ~27 million covered lives. Prior to this career change, Dr. Whalen practiced for over 8 years managing North Memorial Health’s Cancer Center in Robbinsdale, Minnesota. There he had clinical and operational responsibilities over both oncology infusion and retail services, financial patient advocates, Genetic Counselors, and the Tumor Registry program. Dr. Whalen was active in training both residents and students in ambulatory oncology and is a Clinical Assistant Professor for the Integrated Oncology Pharmacotherapy course at the University of Minnesota’s College of Pharmacy. Dr. Whalen also co-founded and is the President of the Upper Midwest Oncology Education Network.
Dr. Whalen received his Doctorate of Pharmacy at Creighton University in Omaha, Nebraska. He then completed a PGY1 at Maine Medical Center in Portland, Maine, where both Dr. Alex Kappelman and Steve D’Amato fostered a passion for oncology pharmacy and introduced him to HOPA. Dr. Whalen was fortunate to then become the first PGY2 Oncology Specialty Resident at the University of Minnesota Medical Center in Minneapolis, Minnesota under Dr. Rebecca (Becky) Fahrenbruch, who remains a close mentor and inspired a commitment of service and advocation for our profession. Dr. Whalen received his board certification in Oncology in 2010. He has been a member of HOPA since 2008 and has been fortunate to pursue his passion in developing and delivering contemporary, quality oncology education within the organization.
Past HOPA Involvement
|- Board of Directors||Member-At-Large||2018–present|
|- Education Development Committee||Member||2017–2018|
|- Program Committee||Chair, Vice Chair, Member||2013–2017|
|- Session Proposal Taskforce||Chair, Member||2011–2015|
|- Membership Committee||Member||2008–2010|